In our patient, the immunohistochemical profile of the MMR proteins was consistent with microsatellite stability in both the DALM and the first adenocarcinoma, whereas both MLH1 expression and PMS2 expression were negative in the subsequent two tumors (Fig. 2a). This evidence concerns the gene MRC1 and adenocarcinoma.